July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Rahul Banerjee: Largest RW Experience with Teclistamab
Jul 10, 2025, 11:12

Rahul Banerjee: Largest RW Experience with Teclistamab

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center at the University of Washington, shared a post on X:

“Now in Blood Cancer Discovery: Largest RW experience with teclistamab ever!

Of 509 US patients (88% TEC-1), ORR 53% and ≥VGPR 45%. mDOR 16 mo if ≥VGPR.

I like ≥VGPR focus, i.e. Multiple Myeloma M-spike not 0 yet. When occurs, DOR similar for BCMA-naive vs exposed more 9 than one month ago!”

Title: Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium

Authors: Beatrice M. Razzo, Shonali Midha, Andrew J. Portuguese, Ariel F. Grajales-Cruz, Andre De Menezes Silva Corraes, Patrick Costello, Yuxin Liu, Adam S. Sperling, Omar Nadeem, Danai Dima, Rahul Banerjee, Andrew J. Cowan, Aimaz Afrough, Larry D. Anderson, Alex Lieberman-Cribbin, Gurbakhash Kaur, Anmol Goyal, Shebli Atrash, Christopher J. Ferreri, Peter M. Voorhees, Oren Pasvolsky, Hans C. Lee, Krina K. Patel, Kelley L. Julian, Peter A. Forsberg, Megan M. Herr, Saurabh Chhabra, Ricardo D. Parrondo, Yi Lin, Anna Chen, Sandra P. Susanibar-Adaniya, Jack Khouri, Shahzad Raza, Faiz Anwer, Mariola Vazquez-Martinez, Omar Castaneda Puglianini, Douglas W. Sborov, James A. Davis, Adriana Rossi, Leyla Shune, Jenny Bhurtel, Wei-Ting Hwang, Doris K. Hansen, Surbhi Sidana, Alfred L. Garfall, Shambavi Richard

Read The Full Article at Blood Cancer Discovery.

Rahul Banerjee: Largest RW Experience with Teclistamab

More posts featuring Rahul Banerjee.